Active ingredientLatanoprostCat. No. P-L025-001CAS 130209-82-4Family · Pharmaceutical analytical standards
Latanoprost
A prostaglandin F2-alpha analogue eye drop, approved in 1996 in the United States and the European Union: it lowers eye pressure by increasing the outflow of aqueous humour, in open-angle glaucoma and ocular hypertension. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?A curious effect is that it can darken the iris, making it browner, and lengthen and thicken the eyelashes: a property later exploited cosmetically with similar medicines.
Go to the active ingredient →Active ingredientLatanoprostCat. No. P-L025-001CAS 130209-82-4
Pharmacopoeial impurityLatanoprost EP Impurity HCat. No. P-L025-002CAS 41639-83-2
Pharmacopoeial impurityLatanoprost EP Impurity ACat. No. P-L025-003
Pharmacopoeial impurityLatanoprost EP Impurity BCat. No. P-L025-004
Pharmacopoeial impurityLatanoprost EP Impurity CCat. No. P-L025-005
Pharmacopoeial impurityLatanoprost EP Impurity DCat. No. P-L025-006CAS 2088449-88-9
Pharmacopoeial impurityLatanoprost EP Impurity ECat. No. P-L025-007CAS 145773-22-4
Pharmacopoeial impurityLatanoprost EP Impurity FCat. No. P-L025-008CAS 913258-34-1
Pharmacopoeial impurityLatanoprost EP Impurity GCat. No. P-L025-009CAS 913258-31-8
Isotopically labelledLatanoprost EP Impurity H-d4Cat. No. P-L025-010CAS 1224443-47-3
Isotopically labelledLatanoprost-d4Cat. No. P-L025-011
ImpurityLatanoprost Impurity 1Cat. No. P-L025-012CAS 856240-62-5
Impurity15(S)-Latanoprostene BunodCat. No. P-L025-014CAS 2099033-64-2
Impurity15-Keto LatanoprostCat. No. P-L025-015CAS 135646-98-9
Impurity15-Keto Latanoprost AcidCat. No. P-L025-016CAS 369585-22-8
Impurity2-Nor LatanoprostCat. No. P-L025-017
Impurity9-Acetyl LatanoprostCat. No. P-L025-018
ImpurityLatanoprost Impurity 2Cat. No. P-L025-019CAS 38754-71-1
ImpurityLatanoprost Enantiomer ImpurityCat. No. P-L025-021
ImpurityLatanoprost Enol ImpurityCat. No. P-L025-022CAS 41639-73-0
ImpurityLatanoprost Epoxide (mixture of isomers)Cat. No. P-L025-023
ImpurityLatanoprost Impurity 3Cat. No. P-L025-025
ImpurityLatanoprost Impurity 4Cat. No. P-L025-028
ImpurityLatanoprost Impurity 5Cat. No. P-L025-029
ImpurityLatanoprost Impurity 6Cat. No. P-L025-030CAS 141074-06-8
ImpurityLatanoprost LactolCat. No. P-L025-032CAS 352276-28-9
ImpurityLatanoprost Lactone DiolCat. No. P-L025-033CAS 145667-75-0
Pharmacopoeial impurityLatanoprost EP Impurity JCat. No. P-L025-034CAS 477884-78-9
ImpurityLatanoprostene BunodCat. No. P-L025-035CAS 860005-21-6
Impuritytrans-(15S)-LatanoprostCat. No. P-L025-048CAS 1235141-39-5
Impuritytrans-Latanoprost AcidCat. No. P-L025-049CAS 903549-49-5
ImpurityLatanoprost Ethyl AmideCat. No. P-L025-050CAS 607351-44-0No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceLatanoprost CRSEDQM code Y0002218Family LatanoprostImpurityLatanoprost impurity H CRSEDQM code Y0002205Family LatanoprostNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.